logo-loader

Medlab Clinical forges ahead in new vitamin trials for chronic illnesses

Last updated: 23:30 07 May 2019 EDT, First published: 09:30 07 May 2019 EDT

Medlab Clinical Ltd (ASX:MDC) chief executive officer Sean Hall tells Proactive Investors how the company is tapping into new areas of its “therapeutic toolkit” to better assist those with chronic health conditions.
 
Hall says there has been a shortfall in the standard of quality healthcare today and Medlab is looking to provide better new health solutions.
 
The company is doing extensive work exploring the role gut health plays in chronic illnesses and developing quality nutraceuticals, popular treatments that contributed towards Medlab's revenue milestones last month.

Xeris Biopharma Surpasses 2023 Expectations with Strategic Moves Poised for...

Xeris Biopharma CEO Paul Edick joined Steve Darling from Proactive to share news the company had a successful 2023, with a final tally of 164 million USD, which is at the upper end of their forecast. The company concluded the year with 72 million USD in cash, surpassing their initial projections...

7 hours, 26 minutes ago